Lapatinib for inflammatory breast cancer.

摘要

Inflammatory breast cancer is characterised by an aggressive nature, a tendency to affect younger women than other breast cancers, a high proportion of local and distant metastases at diagnosis, and low overall survival.1 Modern treatments have so far failed to substantially affect its poor prognosis.